The Disabled Persons Railcard (DPRC) in the UK has expanded its eligibility criteria to include neurodivergent conditions such as ADHD, a move intended to increase accessibility to rail travel. However, the expansion has drawn criticism, with some arguing that taxpayers should not subsidize discounts for what they term 'low-level' mental health disorders.
The Rail Delivery Group, which administers the railcard, updated its criteria last month to encompass conditions that require professional health evidence and a detailed assessment, including neurodiversity that substantially impacts a person's ability to travel by train. Eligible individuals must demonstrate significant disability-related barriers to rail travel.
Rail minister Lord Hendy has previously endorsed the scheme's expansion, calling it a "railcard revolution" that promotes "more accessible, affordable and inclusive rail travel." He stated that the change aims to help disabled people travel with confidence and make it easier for them to access education, employment, and maintain social connections.
Critics, however, express concern that the system could be exploited. Alison Griffiths, the shadow parliamentary under-secretary for transport, told The Telegraph that while discounts for genuine disabilities are reasonable, funding for individuals with "low-level mental health conditions" is not. She pointed to a perceived "sickfluencer" industry that allegedly coaches individuals on how to exploit the system.
The Rail Delivery Group maintains that applications are reviewed on a case-by-case basis. According to Office of Rail and Road statistics, the number of disabled railcard holders has significantly increased, rising from fewer than 200,000 in 2016 to over 450,000 this year.
A Department for Transport spokesperson affirmed that the expansion is "the right thing to do" to improve rail transport access for disabled individuals. The department emphasized that all applications require validation from a medical or social care professional and are evaluated based on the impact of a condition on travel ability, not solely on the diagnosis.